Aug 13 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
SAREPTA THERAPEUTICS ANNOUNCES ADVANCEMENT OF SIRNA COLLABORATION AND SALE OF ARROWHEAD EQUITY INVESTMENT
SAREPTA THERAPEUTICS INC - SAFETY REVIEW TRIGGERS $100 MILLION MILESTONE PAYMENT
SAREPTA THERAPEUTICS INC - SELLS $174 MILLION ARROWHEAD STOCK
SAREPTA THERAPEUTICS INC: EXPECTS TO RELEASE PRELIMINARY DATA FROM PHASE 1/2 STUDY OF SRP-1003 IN H2
SAREPTA THERAPEUTICS : ARROWHEAD WILL REDEEM $50 MILLION OF STOCK FROM CO TO PREFUND HALF OF $100 MILLION MILESTONE PAYMENT DUE TO IT